In Brief: Biogen
Executive Summary
Biogen: Licenses rights to patented protein secretion technology to Pharmacia & Upjohn in exchange for royalties of $30 mil. plus a percentage of sales of the company's Genotropin human growth hormone product. The agreement settles patent litigation brought by Biogen in early 1996 that sought 7% royalties on Genotropin sales in Sweden and Japan and an injunction on sales of the product in the U.S...